Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$50,924,032
-$4,654,290 QoQ
Shares Held
200,512
-11.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#443
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gotham Asset Management, LLC holds $386,755,559 across 13 Drug Manufacturers - General names. JNJ ranks #4 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
528,937 | $67,968,404 | |
| 2 | BIIB |
Biogen Inc.
|
279,900 | $60,475,194 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
892,969 | $51,452,873 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
200,512 | $50,924,032 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
381,851 | $48,243,055 | |
| 6 | ABBV |
AbbVie Inc.
|
108,867 | $27,395,291 | |
| 7 | LLY |
ELI LILLY & Co
|
21,971 | $26,352,678 | |
| 8 | PFE |
Pfizer Inc
|
916,205 | $22,062,216 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,924,032 | 200,512 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $55,578,322 | 227,370 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $49,536,793 | 239,366 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $39,501,135 | 213,036 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $28,158,851 | 184,346 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,323,962 | 98,432 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $28,797,746 | 199,127 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $35,270,252 | 217,637 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $31,866,241 | 218,023 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $27,255,978 | 172,299 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $25,132,161 | 160,343 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $19,467,504 | 124,992 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $18,980,509 | 114,672 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $18,033,010 | 116,342 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $16,110,656 | 91,201 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $15,743,820 | 96,375 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,611,289 | 76,679 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $13,835,814 | 78,067 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $17,544,254 | 102,556 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $18,190,391 | 112,634 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $11,063,114 | 67,155 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $9,301,881 | 56,598 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $19,068,160 | 121,160 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $23,654,054 | 158,880 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $28,075,091 | 199,638 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $19,085,578 | 145,547 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||